Biotech Investing: How Data Is Changing Medicine w/ Aidan Gold 馃敩
3,557 views 路 Published 22 November 2018 路 31:07 路 Indexed 29 September 2026
Channel: HyperChange 路 2018 路 People & Blogs
A conversation with Aidan Gold about the history of biotechnology, where it is today, and the basic business model of bringing a drug to market. We cover topics from immunotherapy, to gene editing, to insurance & the ethics of million dollar treatments. Let me know what you think in the comments! Become a #HyperChanger & support us on Patreon to receive the exclusive weekly HyperChange Newsletter!! https://www.patreon.com/hyperchange LINK - VC trends in biotech investing: https://pitchbook.com/news/articles/is-vcs-insatiable-appetite-for-biotech-sustainable LINK - Juno Therapeutics: https://www.junotherapeutics.com/home/ LINK - Moderna: https://www.modernatx.com/ LINK - Spark: http://sparktx.com/ HyperChange Twitter: https://twitter.com/HyperChangeTV HyperChange Instagram: http://instagram.com/Hyperchange HyperChange Facebook: https://www.facebook.com/HyperChange/ Music by Marko: https://soundcloud.com/markothedon & Fritz Carlton: https://soundcloud.com/fritzcarlton Disclaimer: This video is purely my opinion and should not be regarded as factual information. I am not a financial advisor. This is not a recommendation to buy or sell securities. Do not assume any facts and numbers in this video are accurate. Always do your own due diligence. As of 11/22/2018 HyperChange host (Galileo Russell) is invested in shares of Tesla (TSLA), long Maker & Bitcoin.